Syneos Health, Inc. (SYNH) 2023年CSR报告「NASDAQ」.pdf

《Syneos Health, Inc. (SYNH) 2023年CSR报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《Syneos Health, Inc. (SYNH) 2023年CSR报告「NASDAQ」.pdf（57页珍藏版）》请在三个皮匠报告上搜索。

1、2023 Environmental,Social and Governance(ESG)ReportA Message From Our CEO,Colin ShannonAbout Syneos HealthESG at Syneos Health2023 ESG ImpactAdvancing HealthCaring for PeopleOperating ResponsiblyProtecting the PlanetData and DisclosuresAbout This Report34913152540465158Our CompanyOur RecognitionOur

2、ESG StrategyESG GovernanceContributing to Global GoalsClinical Trial Safety and QualityEthics in Research and Development(R&D)Accessibility and AffordabilityDiversity,Equity and Inclusion(DE&I)Talent Engagement,Recruitment and RetentionEmployee Safety and Well-beingHuman RightsCommunity SupportBusin

3、ess EthicsCorporate GovernancePrivacy and Data SecuritySupply ChainEnergy and Carbon EmissionsClimate ChangeWasteTable of Contents2ESG at Syneos Health2023 ESG ImpactAdvancing HealthCaring for PeopleOperating ResponsiblyProtecting the PlanetData and DisclosuresAbout Syneos HealthA Message From Our C

4、EO,Colin Shannon2023 was a year of transition for our business with the decision to take our company private.At the same time,the work Syneos Health does every day remains consistent.We are committed to supporting our customers deliver important therapies to patients,with the shared goal of advancin

5、g health.To move these efforts forward in a responsible and impactful way,we must continue operating sustainably,focusing on ESG priorities.This guides how we manage non financial risks and take action in areas where we can make the greatest impact.Syneos Health made considerable progress on our ESG

6、 priorities last yearleveraging our expertise and insights to advance our strategy with clear actions that are important both to our customers and to our business.Our work on clinical trials reached more than 375,000 patients in 2023 and is one area in which ESG principles are embedded in our work.W